Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence

NCT01570036 is registered in ClinicalTrials.gov with George E. Peoples as lead sponsor.

NCT NCT01570036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01570036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence
Lead sponsor
George E. Peoples
Phase
Phase 2
Overall status
Completed
Start date
May 21, 2013
Completion date
September 28, 2018
Enrollment
275 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer